NASDAQ: SANA

Sana Biotechnology Inc Stock Forecast, Predictions & Price Target

The consensus among 2 Wall Street analysts covering (NASDAQ: SANA) stock is to Buy SANA stock.

Out of 2 analysts, 0 (0%) are recommending SANA as a Strong Buy, 2 (100%) are recommending SANA as a Buy, 0 (0%) are recommending SANA as a Hold, 0 (0%) are recommending SANA as a Sell, and 0 (0%) are recommending SANA as a Strong Sell.

If you're new to stock investing, here's how to buy Sana Biotechnology stock.

(NASDAQ: SANA) Sana Biotechnology's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 37.96%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.23%.

Sana Biotechnology's revenue in 2024 is $0.On average, 1 Wall Street analysts forecast SANA's revenue for 2027 to be $5,092,338,567, with the lowest SANA revenue forecast at $5,092,338,567, and the highest SANA revenue forecast at $5,092,338,567. On average, 1 Wall Street analysts forecast SANA's revenue for 2028 to be $23,036,769,707, with the lowest SANA revenue forecast at $23,036,769,707, and the highest SANA revenue forecast at $23,036,769,707.

In 2029, SANA is forecast to generate $58,683,139,673 in revenue, with the lowest revenue forecast at $58,683,139,673 and the highest revenue forecast at $58,683,139,673.

According to 2 Wall Street analysts that have issued a 1 year SANA price target, the average SANA price target is $13.50, with the highest SANA stock price forecast at $15.00 and the lowest SANA stock price forecast at $12.00.

On average, Wall Street analysts predict that Sana Biotechnology's share price could reach $13.50 by Mar 1, 2025. The average Sana Biotechnology stock price prediction forecasts a potential upside of 74.64% from the current SANA share price of $7.73.

(NASDAQ: SANA) forecast ROE is N/A, which is considered weak.